Skip to content
Danforth Advisors
Magnifying Glass Icon
Primary Menu Toggle Icon
  • Capabilities
    • Operational Finance and Accounting
    • Financing Strategy and Execution
    • IPO Preparation and Execution
    • Accounting and Reporting Advisory
    • Human Resources
    • Risk Management
  • How We Work
    • Client Success
  • News/Resources
  • Our Team
    • Join Us
  • Contact Us

Resources

  • Biotech Risk Management: How to Protect Your Life Sciences Organization

    Insights on the importance of risk assessment and mitigation strategies

  • Biotech CEOs Should Focus on Optionality to Land the Best Opportunity

    The importance of readiness, strategic differentiation, and de-risking the science to attract investors

  • Danforth Advisors Acquires VPMR

    We now provide global market research to inform strategy for life science companies

Fact Sheets
SEC Reporting Rules for Cyber Security

What public biotech companies need to know about SEC reporting rules for cyber security

Podcast
Podcast: Navigating the Biotech Development Journey

How Emerging Biotechs Can Remain Capital-Efficient While Accessing Seasoned Talent

Corporate News
Danforth Advisors Expands to Europe with Launch of UK Operations

UK operations to be led by Michael Cunniffe, Managing Director

Insights
Mitigating the Impact of Risk in Preclinical Drug Development

Control risk to minimize its impact on time and resources

Corporate News
Danforth Advisors Names Dan Dehner Managing Director

Leadership team news

Corporate News
Danforth Advisors Acquires BW Health Group

We now provide commercial readiness and launch services for small to mid-sized life science companies

Insights
Early Engagement in Drug Development: Why It Matters and How to Achieve It

Learn how Elite Biopharma Consulting can help

Corporate News
Danforth Advisors Acquires Advyzom

Establishes complete range of clinical and regulatory services for life science companies

Insights
When to Engage Clinical Development Experts

Early engagement with clinical development experts can provide significant strategic advantages

Corporate News
Danforth Advisors Acquires VPMR

We now provide global market research to inform strategy for life science companies

Corporate News
Ganda Business Solutions and Danforth Advisors Align to Support Swiss Biotechs

Providing strategic and operational support to help Swiss biotechs scale and expand to the US

Insights
The Cost of Waiting: Why Early Biotech Commercial Planning Is Essential for Success

Discover the cost of delaying building your biotech commercial strategy.

Insights
Start Here: 5 Key Steps to Build a Biotech Compensation Strategy

Learn how to build a thoughtful compensation strategy for your biotech company.

Insights
How Small Biopharma Teams Can Punch Above Their Weight in Clinical Operations 

Discover how small biopharma teams can drive success in clinical operations.

Corporate News
Danforth Advisors Establishes Market Access Division

Helping life science companies simplify market access, navigate payer complexity and guide reimbursement strategy

Insights
How to Improve Collaboration Around Clinical Trial Financial Accruals

Learn how to bridge the gap between clinical operations and accounting.

Insights
Clinical Trial Financial Accruals: What Every Clinical Professional Needs to Know

Best practices for improved accuracy in clinical forecasting and financial reporting.

Insights
CRO Contract Best Practices: Why life science companies should treat CRO contracting as a strategic asset, not just a legal formality. 

Discover a smarter CRO selection strategy that aligns with your clinical trial goals, resources, and long-term success.

  • Capabilities
  • How We Work
  • News/Resources
  • Danforth Inside
  • Our Team
  • Join Us
  • Contact Us
  • Sitemap
  • Terms and Conditions
  • Privacy Policy
  • Subscribe to our quarterly newsletter for insights, news, and events.

©2026 Danforth Advisors. All Rights Reserved.

Knowledge. Discipline. Perspective.